95 related articles for article (PubMed ID: 7723730)
1. Topoisomerase II alpha promoter trans-activation early in monocytic differentiation of HL-60 human leukemia cells.
Fraser DJ; Brandt TL; Kroll DJ
Mol Pharmacol; 1995 Apr; 47(4):696-706. PubMed ID: 7723730
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of a potentially phorbol-regulatable region of the human topoisomerase II alpha gene promoter.
Loflin PT; Hochhauser D; Hickson ID; Morales F; Zwelling LA
Biochem Biophys Res Commun; 1994 Apr; 200(1):489-96. PubMed ID: 8166723
[TBL] [Abstract][Full Text] [Related]
3. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.
Constantinou A; Henning-Chubb C; Huberman E
Cancer Res; 1989 Mar; 49(5):1110-7. PubMed ID: 2537141
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K
Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635
[TBL] [Abstract][Full Text] [Related]
6. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M
Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155
[TBL] [Abstract][Full Text] [Related]
7. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
Harker WG; Slade DL; Parr RL; Holguin MH
Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of poly(ADP-ribose) polymerase promotes cell cycle arrest and inhibits neutrophilic differentiation of NB4 acute promyelocytic leukemia cells.
Bhatia M; Kirkland JB; Meckling-Gill KA
Cell Growth Differ; 1996 Jan; 7(1):91-100. PubMed ID: 8788037
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
10. Activation of interleukin-1 beta gene expression during retinoic acid-induced granulocytic differentiation of promyeloid leukemia cells.
Matikainen S; Tapiovaara H; Vaheri A; Hurme M
Cell Growth Differ; 1994 Sep; 5(9):975-82. PubMed ID: 7819135
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus.
McPherson JP; Brown GA; Goldenberg GJ
Cancer Res; 1993 Dec; 53(24):5885-9. PubMed ID: 8261398
[TBL] [Abstract][Full Text] [Related]
12. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
[TBL] [Abstract][Full Text] [Related]
13. Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
Ganapathi R; Constantinou A; Kamath N; Dubyak G; Grabowski D; Krivacic K
Mol Pharmacol; 1996 Aug; 50(2):243-8. PubMed ID: 8700130
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-alpha and topoisomerase II alpha in prostate cancer.
Lee CH; Liu M; Sie KL; Lee MS
Anticancer Res; 1996; 16(4A):1805-11. PubMed ID: 8712704
[TBL] [Abstract][Full Text] [Related]
15. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
Harris LN; Yang L; Tang C; Yang D; Lupu R
Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
[TBL] [Abstract][Full Text] [Related]
16. Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.
Zwelling LA; Hinds M; Chan D; Altschuler E; Mayes J; Zipf TF
Cancer Res; 1990 Nov; 50(22):7116-22. PubMed ID: 2171756
[TBL] [Abstract][Full Text] [Related]
17. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.
Constantinou AI; Vaughan AT; Yamasaki H; Kamath N
Cancer Res; 1996 Sep; 56(18):4192-9. PubMed ID: 8797591
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle-dependent regulation of the mouse DNA topoisomerase IIalpha gene promoter.
Adachi N; Kobayashi M; Koyama H
Biochem Biophys Res Commun; 1997 Jan; 230(1):105-9. PubMed ID: 9020022
[TBL] [Abstract][Full Text] [Related]
19. JWA, a novel signaling molecule, involved in all-trans retinoic acid induced differentiation of HL-60 cells.
Huang S; Shen Q; Mao WG; Li AP; Ye J; Liu QZ; Zou CP; Zhou JW
J Biomed Sci; 2006 May; 13(3):357-71. PubMed ID: 16468075
[TBL] [Abstract][Full Text] [Related]
20. Sp1 and NF-kappaB transcription factor activity in the regulation of the p21 and FasL promoters during promyelocytic leukemia cell monocytic differentiation and its associated apoptosis.
Savickiene J; Treigyte G; Pivoriunas A; Navakauskiene R; Magnusson KE
Ann N Y Acad Sci; 2004 Dec; 1030():569-77. PubMed ID: 15659839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]